Brief: EVOTEC Q2 Group Revenues €143.50 Mln
13/08/2026 06:33
BRIEF-EVOTEC Q2 Group Revenues €143.50 Mln Aug 13 (Reuters) - EVOTEC SE EVTG.DE:
EVOTEC ANNOUNCES SECOND QUARTER AND FIRST HALF 2026 RESULTS: GROWING COMMERCIAL MOMENTUM
Q2 GROUP REVENUES €143.50 MILLION, H1 €300.10 MILLION; Q2 ADJUSTED EBITDA -€20.80 MILLION, H1 -€42.70 MILLION
UPDATED FY 2026 OUTLOOK: EXPECTED GROUP REVENUES OF EUR 570 TO EUR 610 M (EUR 595 TO 635 M CER) AND ADJUSTED. GROUP EBITDA OF -EUR 70 TO -EUR 105 M (-EUR 60 TO -EUR 90 M CER)
CAMILLA MACAPILI LANGUILLE STEPS DOWN FROM SUPERVISORY BOARD
Source text: ID:nEQNW5pva
Further company coverage: EVTG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Evotec SE
See all newsEvotec up 7% in early trade after 9-month revenue, earnings beat
Brief: Evotec Says Preliminary Nine-Month 2026 Results Above Market Expectations
Brief: Evotec Initiates Phase 1 Trial For Jst-018 Antibodies Targeting Orthopoxviruses
Brief: EVOTEC Q2 Group Revenues €143.50 Mln
Brief: Evotec And Odyssey Therapeutics Enter AI-Enabled R&D Collaboration In Autoimmune And Inflammatory Diseases